Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA080098-14
Application #
8248329
Study Section
Special Emphasis Panel (ZCA1-SRRB-9 (O1))
Program Officer
Henderson, Lori A
Project Start
1999-03-06
Project End
2014-12-31
Budget Start
2012-01-01
Budget End
2014-12-31
Support Year
14
Fiscal Year
2012
Total Cost
$3,138,212
Indirect Cost
$1,261,912
Name
American College of Radiology
Department
Type
DUNS #
062485800
City
Reston
State
VA
Country
United States
Zip Code
20191
Cureton, Elizabeth L; Yau, Christina; Alvarado, Michael D et al. (2014) Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657). Ann Surg Oncol 21:2889-96
National Lung Screening Trial Research Team; Church, Timothy R; Black, William C et al. (2013) Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 368:1980-91
Abrams, Jeffrey S; Mooney, Margaret M; Zwiebel, James A et al. (2013) Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials. J Natl Cancer Inst 105:954-9
Lin, Cheryl; Buxton, Meredith Becker; Moore, Dan et al. (2012) Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial). Breast Cancer Res Treat 132:871-9
Esserman, Laura J; Berry, Donald A; Cheang, Maggie C U et al. (2012) Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res Treat 132:1049-62
Berg, Wendie A; Zhang, Zheng; Lehrer, Daniel et al. (2012) Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 307:1394-404